The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 13, Issue 2, 2011, Pages

  Ekwall, Anna Karin H ^a   Eisler, Thomas ^a   Anderberg, Christian ^b   Jin, Chunsheng ^c   Karlsson, Niclas ^c   Brisslert, Mikael ^a   Bokarewa, Maria I ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Spenshult Hospital   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CADHERIN; CYTOKINE; GELATINASE B; GROWTH FACTOR; INTERLEUKIN 1BETA; PODOPLANIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; MEMBRANE PROTEIN; PDPN PROTEIN, HUMAN;

ARTICLE; CELL MIGRATION; CELL SUBPOPULATION; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; OSTEOARTHRITIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; TISSUE CULTURE; UPREGULATION; WESTERN BLOTTING; AGED; BIOSYNTHESIS; CELL SEPARATION; CONFOCAL MICROSCOPY; CYTOLOGY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELL SEPARATION; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; SYNOVIAL MEMBRANE;

EID: 79952344615     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3274     Document Type: Article

References (49)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361. 10.1038/nature01661, 12748655.
2. Müller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 2005, 1:102-110.
3. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009, 373:659-672. 10.1016/S0140-6736(09)60008-8, 19157532.
4. van Vollenhoven RF. Treatment of rheumatoid arthritis: state of the art 2009. Nat Rev Rheumatol 2009, 5:531-541. 10.1038/nrrheum.2009.182, 19798027.
5. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010, 233:233-255. 10.1111/j.0105-2896.2009.00859.x, 2913689, 20193003.
6. Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE, Huizinga TW. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum 2005, 52:1999-2002. 10.1002/art.21118, 15986342.
7. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:669-675. 10.1093/rheumatology/kel065, 16567358.
8. Iwanaga T, Shikichi M, Kitamura H, Yanase H, Nozawa-Inoue K. Morphology and functional roles of synoviocytes in the joint. Arch Histol Cytol 2000, 63:17-31. 10.1679/aohc.63.17, 10770586.
9. Firestein GS. Biomedicine: every joint has a silver lining. Science 2007, 315:952-953. 10.1126/science.1139574, 17303744.
10. Valencia X, Higgins JM, Kiener HP, Lee DM, Podrebarac TA, Dascher CC, Watts GF, Mizoguchi E, Simmons B, Patel DD, Bhan AK, Brenner MB. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med 2004, 200:1673-1679. 10.1084/jem.20041545, 2211995, 15611293.
11. Chang SK, Gu Z, Brenner MB. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol Rev 2010, 233:256-266. 10.1111/j.0105-2896.2009.00854.x, 20193004.
12. Trollmo C, Nilsson IM, Sollerman C, Tarkowski A. Expression of the mucosal lymphocyte integrin α E β 7 and its ligand E-cadherin in the synovium of patients with rheumatoid arthritis. Scand J Immunol 1996, 44:293-298.
13. Steenvoorden MM, Tolboom TC, van der Pluijm G, Lowik C, Visser CP, DeGroot J, Gittenberger-DeGroot AC, DeRuiter MC, Wisse BJ, Huizinga TW, Toes RE. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther 2006, 8:R165. 10.1186/ar2073, 1794508, 17076892.
14. Kiener HP, Lee DM, Agarwal SK, Brenner MB. Cadherin-11 induces rheumatoid arthritis fibroblast-like synoviocytes to form lining layers in vitro. Am J Pathol 2006, 168:1486-1499. 10.2353/ajpath.2006.050999, 1606584, 16651616.
15. Lee DM, Kiener HP, Agarwal SK, Noss EH, Watts GF, Chisaka O, Takeichi M, Brenner MB. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007, 315:1006-1010. 10.1126/science.1137306, 17255475.
16. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 2005, 115:118-128. 10.1016/j.clim.2004.12.009, 15885632.
17. Davis LS. A question of transformation: the synovial fibroblast in rheumatoid arthritis. Am J Pathol 2003, 162:1399-1402. 10.1016/S0002-9440(10)64272-1, 1851189, 12707022.
18. Meyer LH, Franssen L, Pap T. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis. Best Pract Res Clin Rheumatol 2006, 20:969-981. 10.1016/j.berh.2006.06.005, 16980218.
19. Noss EH, Brenner MB. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 2008, 223:252-270. 10.1111/j.1600-065X.2008.00648.x, 18613841.
20. Baier A, Meineckel I, Gay S, Pap T. Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 2003, 15:274-279. 10.1097/00002281-200305000-00015, 12707581.
21. Karouzakis E, Gay RE, Gay S, Neidhart M. Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol 2009, 5:266-272. 10.1038/nrrheum.2009.55, 19412193.
22. Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996, 149:1607-1615. 1865262, 8909250.
23. Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG, Baltus B, Huizinga TW, Pieterman E, Fero M, Firestein GS, van der Pouw Kraan TC, Verweij CL. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 2005, 52:430-441. 10.1002/art.20811, 15692990.
24. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428. 10.1172/JCI39104, 2689101, 19487818.
25. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503. 10.1002/path.1427, 12845617.
26. Lefèvre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, Korb A, Schnäker EM, Tarner IH, Robbins PD, Evans CH, Stürz H, Steinmeyer J, Gay S, Schölmerich J, Pap T, Müller-Ladner U, Neumann E. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009, 15:1414-1420.
27. Martín-Villar E, Scholl FG, Gamallo C, Yurrita MM, Muñoz-Guerra M, Cruces J, Quintanilla M. Characterization of human PA2.26 antigen (T1α-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 2005, 113:899-910.
28. Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, Harvey N, Williams M, Dvorak AM, Dvorak HF, Oliver G, Detmar M. T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003, 22:3546-3556. 10.1093/emboj/cdg342, 165612, 12853470.
29. Hultgård-Ekwall AK, Mayerl C, Rubin K, Wick G, Rask-Andersen H. An interstitial network of podoplanin-expressing cells in the human endolymphatic duct. J Assoc Res Otolaryngol 2006, 7:38-47. 2504586, 16408168.
30. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006, 9:261-272. 10.1016/j.ccr.2006.03.010, 16616332.
31. Kato Y, Fujita N, Kunita A, Sato S, Kaneko M, Osawa M, Tsuruo T. Molecular identification of Aggrus/T1α as a platelet aggregation-inducing factor expressed in colorectal tumors. J Biol Chem 2003, 278:51599-51605. 10.1074/jbc.M309935200, 14522983.
32. Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. Br J Cancer 2007, 96:1-5. 10.1038/sj.bjc.6603518, 2360213, 17179989.
33. Kawase A, Ishii G, Nagai K, Ito T, Nagano T, Murata Y, Hishida T, Nishimura M, Yoshida J, Suzuki K, Ochiai A. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer 2008, 123:1053-1059. 10.1002/ijc.23611, 18546264.
34. Gandarillas A, Scholl FG, Benito N, Gamallo C, Quintanilla M. Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis. Mol Carcinog 1997, 20:10-18. 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M, 9328432.
35. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
36. Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol 1995, 22:1974-1975.
37. Fujiki Y, Hubbard AL, Fowler S, Lazarow PB. Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J Cell Biol 1982, 93:97-102. 10.1083/jcb.93.1.97, 2112113, 7068762.
38. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543. 10.2741/1817, 16146751.
39. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 1996, 39:1576-1587. 10.1002/art.1780390919, 8814070.
40. Xu G, Redard M, Gabbiani G, Neuville P. Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am J Pathol 1997, 151:1741-1749. 1858370, 9403724.
41. Eyden B. Fibroblast phenotype plasticity: relevance for understanding heterogeneity in fibroblastic tumors. Ultrastruct Pathol 2004, 28:307-319. 10.1080/019131290882204, 15764579.
42. Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 1997, 151:1141-1152. 1858024, 9327748.
43. Scholl FG, Gamallo C, Vilaró S, Quintanilla M. Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J Cell Sci 1999, 112:4601-4613.
44. Martín-Villar E, Megías D, Castel S, Yurrita MM, Vilaró S, Quintanilla M. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci 2006, 119:4541-4553.
45. Zimmermann T, Kunisch E, Pfeiffer R, Hirth A, Stahl HD, Sack U, Laube A, Liesaus E, Roth A, Palombo-Kinne E, Emmrich F, Kinne RW. Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture: primary culture cells markedly differ from fourth-passage cells. Arthritis Res 2001, 3:72-76. 10.1186/ar142, 17827, 11178129.
46. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002, 99:12877-12882. 10.1073/pnas.162488599, 130553, 12297622.
47. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003, 13:264-269. 10.1016/S0962-8924(03)00057-6, 12742170.
48. Suzuki H, Kato Y, Kaneko MK, Okita Y, Narimatsu H, Kato M. Induction of podoplanin by transforming growth factor-β in human fibrosarcoma. FEBS Lett 2008, 582:341-345. 10.1016/j.febslet.2007.12.028, 18158922.
49. Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, Kinne RW. Constitutive upregulation of the transforming growth factor-β pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2007, 9:R59. 10.1186/ar2217, 2206335, 17594488.